VLX-1005

DB18307InvestigationalSmall molecule

VLX-1005: Overview.

Chemical structure of VLX-1005
Formula / weight
C21H19N3O4S2 · 441.52 g/mol (avg)
Also known as
Benzenesulfonamide, n-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)- · N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)benzenesulfonamide · N-Benzothiazol-2-yl-4-(2-hydroxy-3-methoxy-benzylamino)-bezenesulfonamide
Code names
ML-355 · VLX-1005

Resolves to

Compound
UNIIJKU4XCC48YCAS1532593-30-8ChEMBLCHEMBL3113165
Structure
InChIKeyOWHBVKBNNRYMIN-UHFFFAOYSA-NSMILESCOC1=CC=CC(CNC2=CC=C(C=C2)S(=O)(=O)NC2=NC3=CC=CC=C3S2)=C1O
Targets
O75342ALOX12B

What you can answer from here — as of April 23, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
3Clinical trialsPhase, status and sponsor resolved per trial
Sign in
1+ReferenceStructured and connected to the statements they support
Sign in

Which drugs share a target with VLX-1005, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In